Back
Nihon Kohden Vs. Nxera Pharma Industry Stock Comparison
Sell
43
NHNKY
Nihon Kohden
Last Price:
14.11
Seasonality Move:
1.12%
Sell
16
SOLTF
Nxera Pharma
Last Price:
9.55
Seasonality Move:
15.46%
Sell
43
Nihon Kohden (NHNKY)
is a Sell
Is Nihon Kohden a Buy, Sell or Hold?
- The current Nihon Kohden [NHNKY] share price is $13.94. The Score for NHNKY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- NHNKY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
16
Nxera Pharma (SOLTF)
is a Sell
Is Nxera Pharma a Buy, Sell or Hold?
- The current Nxera Pharma [SOLTF] share price is $9.30. The Score for SOLTF is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- SOLTF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
NHNKY Stock Price Chart
What is Nihon Kohden's stock price today?
-
The Nihon Kohden share price today is $13.94
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NHNKY is experiencing slight selling pressure.
SOLTF Stock Price Chart
What is Nxera Pharma's stock price today?
-
The Nxera Pharma share price today is $9.30
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SOLTF is experiencing slight buying pressure.
NHNKY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 58.79 | Buy |
| Chaikin Money Flow: | -271 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.99 - 13.61) | Buy |
| Bollinger Bands (100): | (13.02 - 15.02) | Sell |
SOLTF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.27 | Sell |
| Relative Strength Index (14 RSI): | 30.53 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.48 - 10.44) | Sell |
| Bollinger Bands (100): | (9.25 - 10.81) | Sell |
NHNKY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.67 | Buy |
| 20-day SMA: | 13.37 | Buy |
| 50-day SMA: | 13.46 | Buy |
| 200-day SMA: | 13.36 | Buy |
| 8-day EMA: | 13.67 | Buy |
| 20-day EMA: | 13.5 | Buy |
| 50-day EMA: | 13.55 | Buy |
| 200-day EMA: | 13.46 | Buy |
SOLTF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.46 | Sell |
| 20-day SMA: | 9.85 | Sell |
| 50-day SMA: | 10.1 | Sell |
| 200-day SMA: | 10.28 | Sell |
| 8-day EMA: | 9.45 | Sell |
| 20-day EMA: | 9.74 | Sell |
| 50-day EMA: | 9.97 | Sell |
| 200-day EMA: | 10.88 | Sell |
Nihon Kohden Earnings Growth & NHNKY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nxera Pharma Earnings Growth & SOLTF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nihon Kohden Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nxera Pharma Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||